ANGIOCRINE BIOSCIENCE
Angiocrine Bioscience has developed a cellular platform for amplifying stem and progenitor cells, in both human and mouse models, by recapitulating the proliferative stimulation of the in vivo vascular niche in vitro. The expansion capacity is on an unprecedented scale when compared to any other competing technology, and it is achieved without the requirement for costly media additives. This process can meet the needs of a broad range of therapeutic, diagnostic, and research applications. We look forward to the expansive application of this technology to help fulfill the promise of tissue-specific engineering and organ-regeneration.
ANGIOCRINE BIOSCIENCE
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.angiocrinebioscience.com
Total Employee:
1+
Status:
Active
Contact:
530-745-9560
Total Funding:
62.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins Nginx
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
John Jaskowiak Chief Operating Officer @ Angiocrine Bioscience
Chief Operating Officer
2017-11-01
Jeffrey Port Co-Founder & Chairman @ Angiocrine Bioscience
Co-Founder & Chairman
2012-11-01
Paul Finnegan Chief Executive Officer @ Angiocrine Bioscience
Chief Executive Officer
2015-05-01
C. Geoffrey Davis President and CSO @ Angiocrine Bioscience
President and CSO
2015-06-01
John Fraser Chief Scientific Officer @ Angiocrine Bioscience
Chief Scientific Officer
2019-08-01
Shahin Rafii Scientific Founder @ Angiocrine Bioscience
Scientific Founder
John Lomoro Chief Financial Officer @ Angiocrine Bioscience
Chief Financial Officer
2021-04-01
John Klacking Co-Founder @ Angiocrine Bioscience
Co-Founder
2011-02-01
Founder
Official Site Inspections
http://www.angiocrinebioscience.com
- Host name: 201.34.196.104.bc.googleusercontent.com
- IP address: 104.196.34.201
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Angiocrine Bioscience"
Our Story - Angiocrine Bioscience
Angiocrine Bioscience is a private, clinical stage cell and gene therapy company based in San Diego, California. Angiocrine Bioscience began as a start-up located within Weill Cornell Medical College (New York City) and then …See details»
Angiocrine Bioscience - PitchBook
Www.angiocrinebioscience.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 11696 Sorrento Valley Road; Suite 200; San Diego, CA 92121; United StatesSee details»
Angiocrine Bioscience, Inc. | LinkedIn
Angiocrine Bioscience is a private, clinical stage engineered cell therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function …See details»
Angiocrine Bioscience, Inc. Company Profile | San Diego, CA ...
Find company research, competitor information, contact details & financial data for Angiocrine Bioscience, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Angiocrine Bioscience - Crunchbase Company Profile …
Angiocrine Bioscience has developed a cellular platform for amplifying stem and progenitor cells, in both human and mouse models, by recapitulating the proliferative stimulation of the in vivo vascular niche in vitro.See details»
Angiocrine Bioscience, Inc. Overview | SignalHire Company Profile
Organization Website: angiocrinebioscience.com : Phone Number (877) 784-8496: Angiocrine Bioscienc... industries Biotech: Headquarters Location: 11575 Sorrento Valley Rd, San Diego, …See details»
Executive Leadership - Angiocrine Bioscience
Dr. Finnegan is Chief Executive Officer of Angiocrine Bioscience. He has more than 20 years of life science management experience in the biotechnology, pharmaceutical, and healthcare industries – including extensive operational …See details»
Angiocrine Bioscience - Overview, News & Similar companies
May 2, 2020 Angiocrine Bioscience contact info: Phone number: (858) 345-1396 Website: www.angiocrinebioscience.com What does Angiocrine Bioscience do? Angiocrine Bioscience …See details»
Angiocrine Bioscience - Org Chart, Teams, Culture & Jobs | The Org
Angiocrine Bioscience is a private, clinical-stage cell and gene therapy company harnessing the power of genetically modified human endothelial cells to regenerate tissues, restore function …See details»
Angiocrine Bioscience, Inc. Information - RocketReach
Angiocrinebioscience.com; gmail.com; View Similar People. Related Companies ViaCyte. 36 $22.6m Evofem Biosciences. 66 $11.4m Mirati Therapeutics. 287 $72.8m Evoke Canale. 139 …See details»
Angiocrine Bioscience, Inc. - Drug pipelines, Patents ... - Patsnap
Dec 18, 2024 angiocrinebioscience.com. Holding Company | 2012 | New York, United States | 10-50 | angiocrinebioscience.com. Last update 18 Dec 2024. Overview. Pipeline. Deal. …See details»
Angiocrine Bioscience | VentureRadar
Dec 1, 2024 Angiocrine Bioscience develops research and therapeutic products based on stem cell- and endothelial cell-related technologies. ... Find out more about Angiocrine Bioscience, …See details»
Board of Directors - Angiocrine Bioscience
Dr. Finnegan is Chief Executive Officer of Angiocrine Bioscience. He has more than 20 years of life science management experience in the biotechnology, pharmaceutical, and healthcare …See details»
Angiocrine Bioscience - Company Profile - Tracxn
Oct 21, 2024 Angiocrine Bioscience - Therapeutics based on genetically modified endothelial cells.. Raised a total funding of $4M over 1 round from 2 investors. Angiocrine Bioscience has …See details»
Angiocrine Bioscience - Craft
Angiocrine Bioscience has 5 employees at their 1 location and $4 m in total funding,. See insights on Angiocrine Bioscience including office locations, competitors, revenue, financials, …See details»
Angiocrine Bioscience - Work in biotech
Angiocrine Bioscience is developing curative cell therapies to use for regenerative medicine. Endothelial cells that line blood vessels are important for organ function, but also play an …See details»
https://www.angiocrinebioscience.com
Https://www.angiocrinebioscience.comSee details»
Science - Angiocrine Bioscience
What are vascular niches? Endothelial cells and adult progenitor (stem) cells congregate to form vascular ‘stem cell’ niches. These niches have been found in nearly all tissues and organs.See details»
Working at Angiocrine Bioscience - Zippia
Mar 14, 2024 Find out what it's like to work at Angiocrine Bioscience. See what kind of people work at Angiocrine Bioscience, career paths working at Angiocrine Bioscience, company …See details»